 Travis Nemkov
Concepts (611)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 51 | 2025 | 700 | 7.490 |
Why?
| | Blood Preservation | 28 | 2025 | 285 | 3.830 |
Why?
| | Metabolomics | 32 | 2025 | 678 | 3.330 |
Why?
| | Metabolome | 23 | 2023 | 350 | 2.660 |
Why?
| | Hemolysis | 10 | 2025 | 206 | 2.500 |
Why?
| | Blood Donors | 10 | 2025 | 105 | 2.410 |
Why?
| | Glycolysis | 21 | 2025 | 321 | 2.160 |
Why?
| | Erythrocyte Transfusion | 12 | 2025 | 194 | 1.400 |
Why?
| | Drosophila Proteins | 9 | 2025 | 204 | 1.390 |
Why?
| | Drosophila melanogaster | 10 | 2025 | 233 | 1.380 |
Why?
| | Mass Spectrometry | 11 | 2019 | 739 | 1.320 |
Why?
| | High-Throughput Screening Assays | 4 | 2021 | 158 | 1.290 |
Why?
| | Carnitine | 4 | 2024 | 84 | 1.100 |
Why?
| | Hypoxia | 11 | 2024 | 1112 | 1.070 |
Why?
| | Energy Metabolism | 11 | 2024 | 922 | 1.000 |
Why?
| | Amino Acids | 10 | 2023 | 497 | 0.970 |
Why?
| | Oxidative Stress | 14 | 2025 | 1317 | 0.940 |
Why?
| | Animals | 73 | 2025 | 36940 | 0.860 |
Why?
| | Membrane Lipids | 2 | 2021 | 91 | 0.830 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 167 | 0.810 |
Why?
| | Proteomics | 8 | 2025 | 1111 | 0.800 |
Why?
| | Mice | 41 | 2025 | 17787 | 0.770 |
Why?
| | Erythroblasts | 1 | 2022 | 19 | 0.770 |
Why?
| | Blood Platelets | 5 | 2025 | 408 | 0.750 |
Why?
| | Athletic Performance | 1 | 2023 | 79 | 0.740 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 4 | 2025 | 32 | 0.730 |
Why?
| | Lipid Metabolism | 6 | 2021 | 518 | 0.700 |
Why?
| | Purines | 4 | 2022 | 176 | 0.700 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 63 | 0.670 |
Why?
| | Physical Exertion | 1 | 2021 | 215 | 0.640 |
Why?
| | Hemoglobins | 5 | 2024 | 353 | 0.630 |
Why?
| | Leukemia | 2 | 2019 | 240 | 0.630 |
Why?
| | Prescription Drugs | 1 | 2021 | 109 | 0.630 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 278 | 0.610 |
Why?
| | Fatty Acids | 7 | 2024 | 443 | 0.610 |
Why?
| | Iron | 3 | 2025 | 313 | 0.600 |
Why?
| | Humans | 102 | 2025 | 137585 | 0.590 |
Why?
| | Carbon | 2 | 2017 | 216 | 0.590 |
Why?
| | Lymph | 2 | 2016 | 32 | 0.590 |
Why?
| | Cell Death | 1 | 2020 | 374 | 0.580 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 630 | 0.560 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.560 |
Why?
| | Muscle, Skeletal | 9 | 2025 | 1724 | 0.540 |
Why?
| | Anemia | 3 | 2024 | 170 | 0.540 |
Why?
| | Bone Marrow | 1 | 2018 | 286 | 0.530 |
Why?
| | Aging | 8 | 2024 | 1864 | 0.520 |
Why?
| | Altitude Sickness | 5 | 2018 | 153 | 0.500 |
Why?
| | Nitrogen | 1 | 2017 | 168 | 0.490 |
Why?
| | Transfusion Medicine | 1 | 2015 | 12 | 0.490 |
Why?
| | Exercise Tolerance | 3 | 2025 | 279 | 0.490 |
Why?
| | Biomarkers | 10 | 2024 | 4149 | 0.470 |
Why?
| | Oxidation-Reduction | 10 | 2022 | 1060 | 0.470 |
Why?
| | Kynurenine | 5 | 2024 | 114 | 0.460 |
Why?
| | Inflammation | 7 | 2024 | 2837 | 0.460 |
Why?
| | Exercise | 3 | 2023 | 2057 | 0.450 |
Why?
| | Hematopoietic Stem Cells | 3 | 2024 | 406 | 0.450 |
Why?
| | Male | 52 | 2025 | 67762 | 0.440 |
Why?
| | Receptor, Adenosine A2B | 3 | 2021 | 43 | 0.440 |
Why?
| | Lipids | 1 | 2019 | 672 | 0.430 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5757 | 0.410 |
Why?
| | Glucosephosphate Dehydrogenase | 3 | 2025 | 60 | 0.400 |
Why?
| | Mitochondria | 7 | 2025 | 948 | 0.390 |
Why?
| | Taste Buds | 1 | 2015 | 208 | 0.390 |
Why?
| | Hemorrhage | 2 | 2022 | 722 | 0.370 |
Why?
| | Healthy Volunteers | 7 | 2021 | 199 | 0.370 |
Why?
| | Extracellular Vesicles | 2 | 2025 | 146 | 0.370 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 399 | 0.370 |
Why?
| | Oxygen | 5 | 2020 | 931 | 0.360 |
Why?
| | Female | 48 | 2025 | 73304 | 0.350 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 597 | 0.350 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 553 | 0.330 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 801 | 0.330 |
Why?
| | Flavones | 2 | 2019 | 10 | 0.320 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 227 | 0.320 |
Why?
| | Adult | 28 | 2025 | 37929 | 0.320 |
Why?
| | Sphingosine | 3 | 2023 | 46 | 0.310 |
Why?
| | Myelodysplastic Syndromes | 2 | 2023 | 135 | 0.310 |
Why?
| | Blood Banks | 3 | 2019 | 41 | 0.310 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2486 | 0.310 |
Why?
| | Lysophospholipids | 3 | 2023 | 80 | 0.310 |
Why?
| | Altitude | 4 | 2023 | 488 | 0.300 |
Why?
| | Adenine | 2 | 2025 | 271 | 0.300 |
Why?
| | Alcohol Oxidoreductases | 2 | 2025 | 62 | 0.290 |
Why?
| | Neoplasm Proteins | 2 | 2025 | 434 | 0.280 |
Why?
| | Polyamines | 3 | 2024 | 40 | 0.280 |
Why?
| | Blood Transfusion | 4 | 2024 | 325 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2025 | 1242 | 0.270 |
Why?
| | Acclimatization | 3 | 2018 | 177 | 0.270 |
Why?
| | Thrombosis | 2 | 2022 | 371 | 0.270 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 422 | 0.270 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 48 | 0.260 |
Why?
| | Hematopoiesis | 2 | 2018 | 192 | 0.260 |
Why?
| | Wounds and Injuries | 3 | 2020 | 758 | 0.260 |
Why?
| | Arginine | 3 | 2024 | 271 | 0.260 |
Why?
| | Mammals | 3 | 2023 | 283 | 0.260 |
Why?
| | Proteome | 4 | 2020 | 472 | 0.260 |
Why?
| | Erythrocyte Aging | 2 | 2024 | 17 | 0.260 |
Why?
| | Sciuridae | 2 | 2019 | 147 | 0.260 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 56 | 0.250 |
Why?
| | Plasma | 3 | 2017 | 212 | 0.250 |
Why?
| | Oxygen Consumption | 4 | 2024 | 696 | 0.250 |
Why?
| | Isotope Labeling | 2 | 2017 | 81 | 0.250 |
Why?
| | Mice, Knockout | 6 | 2025 | 3015 | 0.250 |
Why?
| | Tryptophan | 4 | 2021 | 183 | 0.250 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 496 | 0.240 |
Why?
| | Drosophila | 2 | 2024 | 154 | 0.240 |
Why?
| | Insulin Resistance | 3 | 2021 | 1208 | 0.240 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 176 | 0.240 |
Why?
| | Collagen | 2 | 2020 | 452 | 0.240 |
Why?
| | Erythropoiesis | 2 | 2023 | 55 | 0.240 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 2025 | 6 | 0.240 |
Why?
| | Qa-SNARE Proteins | 1 | 2025 | 20 | 0.240 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 373 | 0.240 |
Why?
| | Rats | 7 | 2021 | 5647 | 0.240 |
Why?
| | Coronavirus Infections | 2 | 2020 | 364 | 0.230 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2025 | 122 | 0.230 |
Why?
| | Interleukin-1 | 2 | 2021 | 965 | 0.230 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 53 | 0.230 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.230 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 506 | 0.230 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 660 | 0.230 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 93 | 0.230 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.230 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 9 | 0.220 |
Why?
| | Hexokinase | 1 | 2024 | 19 | 0.220 |
Why?
| | Rejuvenation | 1 | 2024 | 19 | 0.220 |
Why?
| | Physical Conditioning, Animal | 2 | 2025 | 257 | 0.220 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 202 | 0.220 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 55 | 0.220 |
Why?
| | Middle Aged | 15 | 2025 | 33479 | 0.220 |
Why?
| | Adenosine Triphosphate | 2 | 2024 | 491 | 0.220 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 14 | 0.220 |
Why?
| | Cell Line, Tumor | 10 | 2023 | 3412 | 0.220 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 116 | 0.220 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 12 | 0.210 |
Why?
| | Blood Group Antigens | 1 | 2023 | 15 | 0.210 |
Why?
| | Emtricitabine | 1 | 2025 | 175 | 0.210 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 29 | 0.210 |
Why?
| | DNA, Mitochondrial | 1 | 2025 | 200 | 0.210 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1092 | 0.210 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 19 | 0.210 |
Why?
| | Uric Acid | 1 | 2025 | 163 | 0.210 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 209 | 0.210 |
Why?
| | Glutamine | 3 | 2019 | 103 | 0.210 |
Why?
| | Chromatography, Liquid | 3 | 2025 | 433 | 0.210 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 29 | 0.210 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 108 | 0.210 |
Why?
| | Isoenzymes | 1 | 2024 | 304 | 0.210 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 45 | 0.210 |
Why?
| | Tenofovir | 1 | 2025 | 243 | 0.210 |
Why?
| | Succinates | 1 | 2023 | 22 | 0.210 |
Why?
| | Larva | 5 | 2025 | 226 | 0.210 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 193 | 0.200 |
Why?
| | Lactates | 1 | 2023 | 85 | 0.200 |
Why?
| | Furin | 1 | 2022 | 14 | 0.200 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 169 | 0.200 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 212 | 0.200 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 80 | 0.200 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 32 | 0.200 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 257 | 0.200 |
Why?
| | Down-Regulation | 1 | 2025 | 657 | 0.200 |
Why?
| | Equidae | 1 | 2022 | 6 | 0.200 |
Why?
| | src-Family Kinases | 1 | 2023 | 92 | 0.200 |
Why?
| | Autophagy | 1 | 2025 | 284 | 0.200 |
Why?
| | Obesity | 5 | 2021 | 2992 | 0.190 |
Why?
| | Histiocytosis | 1 | 2022 | 7 | 0.190 |
Why?
| | Alleles | 1 | 2025 | 891 | 0.190 |
Why?
| | Bicycling | 1 | 2023 | 114 | 0.190 |
Why?
| | Glucose | 3 | 2017 | 1020 | 0.190 |
Why?
| | Liver | 3 | 2019 | 1943 | 0.190 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 4 | 0.190 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 111 | 0.190 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 197 | 0.190 |
Why?
| | Neutrophils | 2 | 2025 | 1238 | 0.180 |
Why?
| | Sulfonamides | 3 | 2020 | 513 | 0.180 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 232 | 0.180 |
Why?
| | Asparagine | 2 | 2018 | 31 | 0.180 |
Why?
| | Transgender Persons | 1 | 2024 | 186 | 0.180 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.180 |
Why?
| | Sphingolipids | 2 | 2021 | 77 | 0.180 |
Why?
| | Cholesterol | 2 | 2022 | 410 | 0.180 |
Why?
| | Erythrocyte Count | 1 | 2021 | 20 | 0.180 |
Why?
| | Auditory Pathways | 1 | 2021 | 52 | 0.180 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 187 | 0.180 |
Why?
| | Lactic Acid | 5 | 2024 | 305 | 0.180 |
Why?
| | Protein Domains | 1 | 2022 | 289 | 0.180 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 65 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 32 | 0.170 |
Why?
| | Syndecan-1 | 1 | 2020 | 38 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 180 | 0.170 |
Why?
| | Virulence Factors | 1 | 2022 | 167 | 0.170 |
Why?
| | Metformin | 1 | 2024 | 331 | 0.170 |
Why?
| | Aged | 8 | 2024 | 23961 | 0.170 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 267 | 0.170 |
Why?
| | Benzothiazoles | 2 | 2017 | 33 | 0.170 |
Why?
| | Testosterone | 1 | 2024 | 409 | 0.170 |
Why?
| | Resistance Training | 1 | 2023 | 164 | 0.170 |
Why?
| | Cell Plasticity | 1 | 2021 | 35 | 0.170 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 94 | 0.170 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1431 | 0.170 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 84 | 0.170 |
Why?
| | Stromal Cells | 1 | 2020 | 112 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 3 | 2025 | 532 | 0.170 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 99 | 0.170 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 122 | 0.170 |
Why?
| | Cannabidiol | 1 | 2022 | 119 | 0.160 |
Why?
| | Osmotic Pressure | 1 | 2020 | 38 | 0.160 |
Why?
| | Cannabinoids | 1 | 2022 | 161 | 0.160 |
Why?
| | Time Factors | 10 | 2024 | 6828 | 0.160 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 17 | 0.160 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 97 | 0.160 |
Why?
| | Taurine | 1 | 2020 | 46 | 0.160 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 25 | 0.160 |
Why?
| | Macrophage Activation | 1 | 2021 | 201 | 0.160 |
Why?
| | Phosphatidylserines | 1 | 2020 | 91 | 0.160 |
Why?
| | Macrophages | 4 | 2022 | 1547 | 0.160 |
Why?
| | Hibernation | 2 | 2019 | 75 | 0.160 |
Why?
| | Transcription Factors | 2 | 2025 | 1719 | 0.160 |
Why?
| | Signal Transduction | 8 | 2025 | 5079 | 0.160 |
Why?
| | Parabiosis | 1 | 2019 | 11 | 0.160 |
Why?
| | Shock | 1 | 2020 | 98 | 0.160 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 206 | 0.160 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 224 | 0.160 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 328 | 0.160 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 34 | 0.160 |
Why?
| | Circadian Clocks | 1 | 2019 | 50 | 0.150 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.150 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 343 | 0.150 |
Why?
| | Machine Learning | 2 | 2021 | 493 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 900 | 0.150 |
Why?
| | Anemia, Sickle Cell | 2 | 2024 | 270 | 0.150 |
Why?
| | Homeostasis | 2 | 2022 | 621 | 0.150 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 465 | 0.150 |
Why?
| | Cigarette Smoking | 1 | 2020 | 101 | 0.150 |
Why?
| | Aspartic Acid | 1 | 2018 | 79 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2024 | 560 | 0.150 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 778 | 0.150 |
Why?
| | Adenosine | 2 | 2017 | 225 | 0.150 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 192 | 0.150 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 41 | 0.150 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1910 | 0.140 |
Why?
| | Arousal | 1 | 2019 | 155 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2020 | 162 | 0.140 |
Why?
| | Stem Cell Niche | 1 | 2018 | 54 | 0.140 |
Why?
| | Transcriptome | 2 | 2021 | 971 | 0.140 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.140 |
Why?
| | Proteostasis | 1 | 2018 | 29 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 200 | 0.140 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 12 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2020 | 243 | 0.140 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.140 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 19 | 0.140 |
Why?
| | Cryopreservation | 1 | 2018 | 100 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 391 | 0.140 |
Why?
| | Benzeneacetamides | 1 | 2017 | 7 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.140 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4295 | 0.140 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.140 |
Why?
| | Resuscitation | 2 | 2018 | 251 | 0.140 |
Why?
| | Thiadiazoles | 1 | 2017 | 23 | 0.140 |
Why?
| | Calcium | 2 | 2022 | 1199 | 0.140 |
Why?
| | Nicotine | 1 | 2020 | 334 | 0.140 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 49 | 0.140 |
Why?
| | Immune System | 1 | 2018 | 177 | 0.130 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 674 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 17 | 0.130 |
Why?
| | Limit of Detection | 1 | 2017 | 85 | 0.130 |
Why?
| | Nitriles | 1 | 2018 | 172 | 0.130 |
Why?
| | Body Fluids | 1 | 2017 | 66 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.130 |
Why?
| | Young Adult | 8 | 2021 | 13209 | 0.130 |
Why?
| | Citric Acid | 1 | 2016 | 33 | 0.130 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 151 | 0.130 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.130 |
Why?
| | Mutation | 6 | 2025 | 3958 | 0.130 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 66 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 41 | 0.130 |
Why?
| | Inflammasomes | 1 | 2018 | 131 | 0.130 |
Why?
| | Neoplasms | 2 | 2022 | 2671 | 0.130 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2189 | 0.130 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2253 | 0.130 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2025 | 860 | 0.130 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 327 | 0.130 |
Why?
| | Folic Acid | 1 | 2017 | 186 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2018 | 279 | 0.120 |
Why?
| | Brain Death | 1 | 2016 | 46 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 383 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2020 | 778 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 121 | 0.120 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 15 | 0.120 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 77 | 0.120 |
Why?
| | Models, Biological | 2 | 2021 | 1783 | 0.120 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 93 | 0.120 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 360 | 0.120 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 7 | 0.120 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 622 | 0.120 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 162 | 0.120 |
Why?
| | Antioxidants | 1 | 2019 | 584 | 0.120 |
Why?
| | Bacteria | 1 | 2022 | 858 | 0.120 |
Why?
| | Biochemistry | 1 | 2015 | 38 | 0.120 |
Why?
| | Anoikis | 1 | 2015 | 31 | 0.120 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.120 |
Why?
| | Acidosis | 1 | 2016 | 101 | 0.120 |
Why?
| | Glutarates | 2 | 2025 | 10 | 0.120 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 147 | 0.120 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 55 | 0.120 |
Why?
| | Fluid Therapy | 1 | 2016 | 147 | 0.120 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 93 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 279 | 0.120 |
Why?
| | Vasodilation | 1 | 2018 | 499 | 0.120 |
Why?
| | Platelet Transfusion | 1 | 2015 | 67 | 0.120 |
Why?
| | Blood Volume | 1 | 2015 | 61 | 0.120 |
Why?
| | Immunity, Innate | 1 | 2021 | 828 | 0.120 |
Why?
| | Pandemics | 2 | 2020 | 1639 | 0.120 |
Why?
| | Citrates | 1 | 2014 | 44 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 617 | 0.110 |
Why?
| | Cell Proliferation | 5 | 2025 | 2475 | 0.110 |
Why?
| | Sulfur | 3 | 2022 | 58 | 0.110 |
Why?
| | Extinction, Biological | 1 | 2015 | 36 | 0.110 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 220 | 0.110 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 45 | 0.110 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 158 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2025 | 2167 | 0.110 |
Why?
| | Cells, Cultured | 5 | 2021 | 4193 | 0.110 |
Why?
| | Linear Models | 1 | 2017 | 849 | 0.110 |
Why?
| | Adipose Tissue | 2 | 2017 | 635 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 792 | 0.110 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 652 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 927 | 0.110 |
Why?
| | Sodium Chloride | 1 | 2014 | 142 | 0.110 |
Why?
| | Phosphates | 1 | 2014 | 182 | 0.110 |
Why?
| | Methionine | 3 | 2020 | 160 | 0.110 |
Why?
| | Proteolysis | 3 | 2020 | 177 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 788 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2017 | 706 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 296 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 561 | 0.100 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 2129 | 0.100 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 366 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 4030 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2531 | 0.100 |
Why?
| | Quantitative Trait Loci | 2 | 2025 | 380 | 0.100 |
Why?
| | Muscles | 2 | 2023 | 326 | 0.100 |
Why?
| | Nuclear Proteins | 1 | 2017 | 712 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 528 | 0.100 |
Why?
| | Diet | 1 | 2020 | 1278 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 605 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 806 | 0.090 |
Why?
| | MicroRNAs | 1 | 2018 | 692 | 0.090 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 2 | 2025 | 16 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 596 | 0.090 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 601 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 872 | 0.080 |
Why?
| | Microbiota | 1 | 2018 | 762 | 0.080 |
Why?
| | Liver Neoplasms | 1 | 2016 | 786 | 0.080 |
Why?
| | HIV Infections | 1 | 2025 | 2836 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 916 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1096 | 0.080 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 57 | 0.080 |
Why?
| | Cell Line | 3 | 2022 | 2847 | 0.080 |
Why?
| | Insulin | 2 | 2021 | 2409 | 0.080 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3284 | 0.080 |
Why?
| | Cattle | 2 | 2022 | 984 | 0.080 |
Why?
| | Phenotype | 4 | 2020 | 3196 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 195 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 938 | 0.070 |
Why?
| | Phosphorylation | 3 | 2018 | 1759 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2019 | 247 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 159 | 0.070 |
Why?
| | Brain | 2 | 2021 | 2668 | 0.070 |
Why?
| | Adolescent | 3 | 2024 | 21513 | 0.070 |
Why?
| | Macaca | 2 | 2018 | 56 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 270 | 0.070 |
Why?
| | Bacterial Proteins | 2 | 2025 | 879 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2021 | 810 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1692 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 201 | 0.070 |
Why?
| | Sex Characteristics | 2 | 2023 | 762 | 0.070 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 41 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1396 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 73 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 660 | 0.060 |
Why?
| | Apoptosis | 3 | 2021 | 2553 | 0.060 |
Why?
| | Cell Adhesion | 2 | 2018 | 466 | 0.060 |
Why?
| | Neurons | 1 | 2015 | 1590 | 0.060 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 411 | 0.060 |
Why?
| | Mice, Nude | 2 | 2018 | 698 | 0.060 |
Why?
| | Isotonic Solutions | 2 | 2016 | 38 | 0.060 |
Why?
| | Biopsy | 2 | 2020 | 1129 | 0.060 |
Why?
| | Swine | 2 | 2018 | 775 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 43 | 0.060 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 59 | 0.060 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 16 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2025 | 59 | 0.060 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 39 | 0.060 |
Why?
| | Plateletpheresis | 1 | 2024 | 27 | 0.060 |
Why?
| | Deferoxamine | 1 | 2024 | 24 | 0.060 |
Why?
| | Antimalarials | 1 | 2024 | 31 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 153 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1120 | 0.060 |
Why?
| | Alanine | 1 | 2025 | 152 | 0.060 |
Why?
| | RNA Interference | 2 | 2017 | 469 | 0.050 |
Why?
| | Cold Temperature | 2 | 2016 | 179 | 0.050 |
Why?
| | Organophosphates | 1 | 2025 | 134 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 10 | 0.050 |
Why?
| | Glutathione | 2 | 2016 | 356 | 0.050 |
Why?
| | Endothelial Cells | 2 | 2020 | 785 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Blood Glucose | 3 | 2020 | 2186 | 0.050 |
Why?
| | Respiratory Therapy | 1 | 2023 | 23 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 886 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 125 | 0.050 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 93 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 115 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 622 | 0.050 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 48 | 0.050 |
Why?
| | Puberty | 1 | 2024 | 146 | 0.050 |
Why?
| | Pantothenic Acid | 1 | 2023 | 6 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2024 | 148 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 7604 | 0.050 |
Why?
| | Dasatinib | 1 | 2023 | 54 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 145 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 53 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 123 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2024 | 189 | 0.050 |
Why?
| | Heme | 1 | 2023 | 78 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 558 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 73 | 0.050 |
Why?
| | Horses | 1 | 2022 | 111 | 0.050 |
Why?
| | Thrombin | 1 | 2022 | 152 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 222 | 0.050 |
Why?
| | Cell Movement | 2 | 2017 | 967 | 0.050 |
Why?
| | Cytokines | 2 | 2022 | 2085 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2022 | 2833 | 0.040 |
Why?
| | Dogs | 1 | 2022 | 413 | 0.040 |
Why?
| | Oncogenes | 1 | 2021 | 116 | 0.040 |
Why?
| | Subcellular Fractions | 1 | 2021 | 82 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 53 | 0.040 |
Why?
| | Candidiasis | 1 | 2021 | 56 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 110 | 0.040 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 14 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2022 | 255 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 143 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 99 | 0.040 |
Why?
| | Point Mutation | 1 | 2021 | 235 | 0.040 |
Why?
| | Cochlea | 1 | 2021 | 72 | 0.040 |
Why?
| | Cystine | 1 | 2020 | 18 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5742 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2023 | 338 | 0.040 |
Why?
| | Muscle Strength | 1 | 2023 | 317 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 239 | 0.040 |
Why?
| | Fat Body | 1 | 2020 | 5 | 0.040 |
Why?
| | Genome | 1 | 2022 | 300 | 0.040 |
Why?
| | Creatine | 1 | 2020 | 57 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 2892 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 165 | 0.040 |
Why?
| | Niacinamide | 1 | 2020 | 82 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 4 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 35 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 20 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 904 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 45 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 391 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 202 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 34 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 194 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 10 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 166 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 155 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 238 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 30 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 93 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 37 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 251 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2071 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 167 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1993 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 94 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 1007 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 570 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 194 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 79 | 0.040 |
Why?
| | Creatinine | 1 | 2020 | 499 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 513 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 654 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 230 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 81 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 43 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 364 | 0.040 |
Why?
| | Formic Acid Esters | 1 | 2017 | 4 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.030 |
Why?
| | Crush Injuries | 1 | 2017 | 12 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2607 | 0.030 |
Why?
| | Metabolism | 1 | 2017 | 42 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5472 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 233 | 0.030 |
Why?
| | Azacitidine | 1 | 2018 | 140 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 82 | 0.030 |
Why?
| | Biological Transport | 1 | 2018 | 418 | 0.030 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 40 | 0.030 |
Why?
| | Pyrroles | 1 | 2018 | 213 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 144 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1502 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2734 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 16 | 0.030 |
Why?
| | Blood Proteins | 1 | 2019 | 252 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 226 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.030 |
Why?
| | Fluorenes | 1 | 2017 | 44 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 22 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 11 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2844 | 0.030 |
Why?
| | Anaerobiosis | 1 | 2017 | 64 | 0.030 |
Why?
| | Cystathionine | 1 | 2016 | 24 | 0.030 |
Why?
| | Periodicity | 1 | 2016 | 58 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1502 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 76 | 0.030 |
Why?
| | Weaning | 1 | 2016 | 47 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 103 | 0.030 |
Why?
| | Nucleotides | 1 | 2017 | 125 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 102 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 23 | 0.030 |
Why?
| | NADP | 1 | 2016 | 49 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 172 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 1009 | 0.030 |
Why?
| | Hydrazines | 1 | 2016 | 35 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 280 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1468 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 236 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 44 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 84 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 53 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 231 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 37 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 55 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 79 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 136 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 80 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 524 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 216 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 98 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 135 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 156 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 594 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 298 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1113 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 222 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 653 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 996 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 372 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 283 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1316 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 309 | 0.030 |
Why?
| | Cysteine | 1 | 2016 | 204 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 265 | 0.030 |
Why?
| | Bison | 1 | 2015 | 6 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 246 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 137 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1570 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 412 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 132 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 218 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 151 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1509 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 249 | 0.030 |
Why?
| | Europe | 1 | 2015 | 414 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 6763 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 276 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 108 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 367 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 499 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1178 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 443 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 945 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 294 | 0.030 |
Why?
| | Running | 1 | 2017 | 230 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 347 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 357 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 692 | 0.030 |
Why?
| | Skull | 1 | 2015 | 139 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1164 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 547 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 1024 | 0.030 |
Why?
| | Postpartum Period | 1 | 2016 | 340 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 625 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 510 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1353 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1066 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 843 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2828 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1325 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2016 | 287 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1457 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 658 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2389 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 452 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3556 | 0.020 |
Why?
| | Athletes | 1 | 2016 | 423 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 806 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 697 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 691 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2139 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 2224 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2900 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10811 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7635 | 0.020 |
Why?
| | United States | 1 | 2015 | 14841 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|